Ym. Wei et al., Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines, ACT PHAR SI, 22(8), 2001, pp. 725-730
AIM: To investigate regulative effects of thiol reagents, N-acetyl-l-cystei
ne (NAC) and natrii dimercaptosussinas (NDMS), catalase (CAT), and calcium
chelator 2-[(2-bis-[carboxymethyl]-amino-5-methyl-phenoxy)-methyl]-6-methox
y-8-bis-[carboxy-methyl]-aminoquinoline (Quin 2) on apoptosis and telomeras
e activity induced by arsenic trioxide (As2O3) in three myelocytic leukemia
cell lines. METHODS: Flow cytometry was used to examine apoptosis and a PC
R ELISA kit was used to detect telomerase activity. RESULTS: As2O3 induced
about 40 % - 60% of apoptosis in NB4, K562, and HL-60 cells at the concentr
ation of 0.6, 2.7, and 8.1 mu mol/L respectively, as well as down-regulated
telomerase activities in three cell lines. NAC 4 mmol/L, NDMS 200 mu mol/L
, CAT 80 kU/L, and Quin 2 20 mu mol/L could down-regulate apoptosis various
ly induced by As2O3. NAC and CAT alone could decline telomerase activity in
three cell lines and further decline telomerase activities that had been d
ecreased by As2O3, whereas Quin 2 antagonized the decline in K562 and HL-60
cells. CONCLUSION: Thiol activity loss, free radical alteration, intracell
ular calcium changes, and decline of telomerase activity might be involved
in As2O3-induced apoptosis. NAC, NDMS, CAT, and Quin 2 antagonized in some
extent the effect of As2O3 on the three tested cell lines.